These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34429000)

  • 1. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
    Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
    Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.
    Matsumori Y; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Takeshima T; Hirata K
    Neurol Ther; 2022 Mar; 11(1):205-222. PubMed ID: 34862581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study.
    Takeshima T; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Matsumori Y; Hirata K
    Adv Ther; 2022 Nov; 39(11):5176-5190. PubMed ID: 36089637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study.
    Lanteri-Minet M; Leroux E; Katsarava Z; Lipton RB; Sakai F; Matharu M; Fanning K; Manack Adams A; Sommer K; Seminerio M; Buse DC
    J Headache Pain; 2024 Aug; 25(1):134. PubMed ID: 39160483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
    Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB
    Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study.
    Pascual J; Núñez M; Panni T; Díaz-Cerezo S; Novick D; Ciudad A
    Pain Ther; 2023 Oct; 12(5):1209-1220. PubMed ID: 37458965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
    Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
    J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.
    Lipton RB; Nicholson RA; Reed ML; Araujo AB; Jaffe DH; Faries DE; Buse DC; Shapiro RE; Ashina S; Cambron-Mellott MJ; Rowland JC; Pearlman EM
    Headache; 2022 Feb; 62(2):122-140. PubMed ID: 35076091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.
    Evers S; Dell'Agnello G; Novick D; Gonderten HS; Panni T; Pascual J
    Pain Ther; 2024 Jun; 13(3):589-607. PubMed ID: 38625512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
    Pascual J; Panni T; Dell'Agnello G; Gonderten S; Novick D; Evers S
    J Headache Pain; 2023 Jul; 24(1):88. PubMed ID: 37460942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underrecognition of migraine-related stigmatizing attitudes and social burden: Results of the OVERCOME Japan study.
    Igarashi H; Komori M; Ueda K; Zagar AJ; Jaffe DH; Matsumori Y; Takeshima T; Hirata K
    Brain Behav; 2024 Jul; 14(7):e3547. PubMed ID: 39054258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
    Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
    Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
    Buse DC; Yugrakh MS; Lee LK; Bell J; Cohen JM; Lipton RB
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1334-1343. PubMed ID: 32678721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
    Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
    Lipton RB; Lanteri-Minet M; Leroux E; Manack Adams A; Contreras-De Lama J; Reed ML; Fanning KM; Buse DC
    J Headache Pain; 2023 Nov; 24(1):151. PubMed ID: 37940856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey.
    Igarashi H; Ueda K; Jung S; Cai Z; Chen Y; Nakamura T
    BMJ Open; 2020 Nov; 10(11):e038987. PubMed ID: 33168555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.